Wyeth Inc. (WYE) News

News for Wyeth Inc.  (WYE) 
Sector News | Topic News
$ N/A N/A (N/A) Volume: N/A
View News From:  
Thu, Oct 15, 2009
7:29 AM Paladin Labs and Pfizer Amend Canadian Estring(R) Agreement - Marketwire Canada
Wed, Oct 14, 2009
2:11 PM Competition Bureau Requires Significant Divestitures in Merger of Pfizer and Wyeth - Marketwire Canada
Fri, Sep 25, 2009
11:10 AM Wyeth Receives Positive Opinion from European Regulators for its 13-valent Pneumococcal Candidate Vaccine for Infants and Young Children - Canada Newswire
Mon, Feb 02, 2009
10:11 AM Technical Trade Alerts on Market Movers: FWLT, ADBE, JDSU, WYE, GSK, JBL - Accesswire
Sat, May 31, 2008
8:43 AM New Analyses Presented at ASCO Reaffirmed Efficacy and Safety of TORISEL in Patients With Advanced Kidney Cancer - Canada Newswire
8:03 AM New Data Show TORISEL Improves Progression-Free Survival for Patients With Relapsed/Refractory Mantle Cell Lymphoma - Canada Newswire
Fri, May 30, 2008
2:04 PM Wyeth Initiates INTORACT -- A New Clinical Trial to Examine TORISEL Plus Avastin for First-Line Treatment of Advanced Kidney Cancer - Canada Newswire
Wed, May 28, 2008
5:26 PM New England Journal of Medicine Publishes Results From a RELISTOR Phase 3 Clinical Study - Canada Newswire
5:16 PM New England Journal of Medicine Publishes Results From a RELISTOR Phase 3 Clinical Study - Canada Newswire